Since taking office in January, President Joe Biden has sought to undo several policies that were established during Donald Trump’s administration. This week, the Biden administration announced another reversal of a Trump-era policy that limited healthcare protections for transgender people.
Health and Human Services Secretary Xavier Becerra announced that the Biden administration is undoing a Trump-era policy against transgender people in healthcare. The rollback was finalized by the Trump administration in June 2020. The protection for transgender people was also regulated by Obamacare, which Trump and the Republicans sought to repeal.
“The Supreme Court has made clear that people have a right not to be discriminated against on the basis of sex and receive equal treatment under the law, no matter their gender identity or sexual orientation. That’s why today HHS announced it will act on related reports of discrimination,” Becerra said in a statement.
“Fear of discrimination can lead individuals to forego care, which can have serious negative health consequences. It is the position of the Department of Health and Human Services that everyone - including LGBTQ people - should be able to access health care, free from discrimination or interference, period,” added Becerra.
Becerra also noted the provision in the Affordable Care Act regarding the protections in an interview with CNN Monday. During Trump’s presidency, HHS announced that it would only recognize discrimination according to the “plain meaning of the world ‘sex’ as male or female and as determined by biology.” The Supreme Court would later rule that the existing federal law prohibits job discrimination based on gender identity or sexual orientation.
Previously, Reuters reported that Biden threw his support towards a proposal made by India and South Africa on temporarily waiving IP patents on COVID-19 vaccines to make them more accessible, especially towards developing countries. Biden confirmed his support for the waiver in his comments to the press.
US Trade Representative Katherine Tai also issued a statement furthering the US’ support for temporarily waiving the IP patents, especially at a time of great need. Many Democratic lawmakers have pushed for a temporary waiver, as did many other countries, despite criticism from the pharmaceutical companies.


Trump Accounts Now Accept Stock Donations as Treasury Launches New Child Investment Program
JD Vance Says Britain Needs Major Political Change as Leadership Transition Looms
South Korea Warns Won Is Undervalued, Boosts FX Coordination With Japan
EU Chip Industry Faces Growing Risks From China Export Controls and U.S. Technology Dependence: Report
OpenAI Proposes 5% U.S. Government Stake Amid AI Policy Talks
Taiwan Simulates Chinese Blockade and Invasion in Major Civil Defense Drill
Trump Offers to Help Advance Ukraine Peace Talks in Call With Putin
Kim Jong Un Oversees North Korea Destroyer Missile Tests, Orders Rapid Naval Deployment
Trump Administration Declines USMCA Renewal, Opens Talks on New Trade Changes
Russia’s Deadly Kyiv Missile and Drone Attack Kills 27 as Zelensky Urges Faster Air Defense Support
UN Warns of Looming Human Rights Catastrophe in Sudan’s Al-Obeid
Russia Claims Capture of Kostiantynivka as Putin Pushes Donetsk Offensive
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
Amy Coney Barrett Faces Conservative Backlash After Key Supreme Court Rulings Against Trump
Moody’s Says Peru’s President-Elect Keiko Fujimori Could Boost Investor Confidence
Trump Administration Proposes Repeal of 702 Federal Regulations in Major Deregulation Push
Air Force Investigates Officer After Capitol Protest Calling for Trump, Vance Impeachment 



